Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 235

1.

Intermittent preventive treatment for malaria in infants.

Esu EB, Oringanje C, Meremikwu MM.

Cochrane Database Syst Rev. 2019 Dec 2;12:CD011525. doi: 10.1002/14651858.CD011525.pub2. Review.

PMID:
31792925
2.

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Abreha T, Adam I, Anstey NM, Assefa A, Awab GR, Baird JK, Barber BE, Chu CS, Dahal P, Daher A, Davis TME, Dondorp AM, Grigg MJ, Humphreys GS, Hwang J, Karunajeewa H, Laman M, Lidia K, Moore BR, Mueller I, Nosten F, Pasaribu AP, Pereira DB, Phyo AP, Poespoprodjo JR, Sibley CH, Stepniewska K, Sutanto I, Thwaites G, Hien TT, White NJ, William T, Woodrow CJ, Guerin PJ, Price RN.

PLoS Med. 2019 Oct 4;16(10):e1002928. doi: 10.1371/journal.pmed.1002928. eCollection 2019 Oct.

3.

A systematic review on anti-malarial drug discovery and antiplasmodial potential of green synthesis mediated metal nanoparticles: overview, challenges and future perspectives.

Kojom Foko LP, Eya'ane Meva F, Eboumbou Moukoko CE, Ntoumba AA, Ngaha Njila MI, Belle Ebanda Kedi P, Ayong L, Lehman LG.

Malar J. 2019 Oct 3;18(1):337. doi: 10.1186/s12936-019-2974-9.

4.

Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.

Kouakou YI, Tod M, Leboucher G, Lavoignat A, Bonnot G, Bienvenu AL, Picot S.

Int J Infect Dis. 2019 Dec;89:30-44. doi: 10.1016/j.ijid.2019.08.030. Epub 2019 Sep 3.

5.

Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.

Ross LS, Fidock DA.

Cell Host Microbe. 2019 Jul 10;26(1):35-47. doi: 10.1016/j.chom.2019.06.001. Review.

PMID:
31295423
6.

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Milligan R, Daher A, Graves PM.

Cochrane Database Syst Rev. 2019 Jul 5;7:CD012656. doi: 10.1002/14651858.CD012656.pub2.

7.

Practical approaches to interpretation of findings from a systematic review and network meta-analysis on efficacy and resistance of different artemisinin-based combination therapies.

Jayaraj R, Kumarasamy C, Madhav MR.

Parasitol Int. 2019 Dec;73:101949. doi: 10.1016/j.parint.2019.101949. Epub 2019 Jun 29. No abstract available.

PMID:
31265924
8.

Artemether for severe malaria.

Esu EB, Effa EE, Opie ON, Meremikwu MM.

Cochrane Database Syst Rev. 2019 Jun 18;6:CD010678. doi: 10.1002/14651858.CD010678.pub3. Review.

9.

A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.

Olaleye A, Okusanya BO, Oduwole O, Esu E, Meremikwu M.

Int J Gynaecol Obstet. 2019 Jul;146(1):43-55. doi: 10.1002/ijgo.12835. Epub 2019 May 25.

PMID:
31050803
10.

Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.

Lee JS, Adhikari NKJ, Kwon HY, Teo K, Siemieniuk R, Lamontagne F, Chan A, Mishra S, Murthy S, Kiiza P, Hajek J, Bah EI, Lamah MC, Kao R, Fowler RA.

BMC Infect Dis. 2019 May 2;19(1):376. doi: 10.1186/s12879-019-3980-9.

11.

Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis.

Mathenge PG, Low SK, Vuong NL, Mohamed MYF, Faraj HA, Alieldin GI, Al Khudari R, Yahia NA, Khan A, Diab OM, Mohamed YM, Zayan AH, Tawfik GM, Huy NT, Hirayama K.

Parasitol Int. 2020 Feb;74:101919. doi: 10.1016/j.parint.2019.04.016. Epub 2019 Apr 20.

PMID:
31015034
12.

Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial Chemotherapy.

Tiwari MK, Yadav DK, Chaudhary S.

Curr Top Med Chem. 2019;19(10):831-846. doi: 10.2174/1568026619666190412104042. Review.

PMID:
30977453
13.

Antiplasmodial Lycorane Alkaloid Principles of the Plant Family Amaryllidaceae.

Nair JJ, van Staden J.

Planta Med. 2019 May;85(8):637-647. doi: 10.1055/a-0880-5414. Epub 2019 Mar 25. Review.

PMID:
30909312
14.

The past, present and future of anti-malarial medicines.

Tse EG, Korsik M, Todd MH.

Malar J. 2019 Mar 22;18(1):93. doi: 10.1186/s12936-019-2724-z. Review.

15.

Small Molecules: The Past or the Future in Drug Innovation?

Robert A, Benoit-Vical F, Liu Y, Meunier B.

Met Ions Life Sci. 2019 Jan 14;19. pii: /books/9783110527872/9783110527872-008/9783110527872-008.xml. doi: 10.1515/9783110527872-008. Review.

PMID:
30855103
16.

Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats.

Bai L, Li H, Li J, Song J, Zhou Y, Liu B, Lu R, Zhang P, Chen J, Chen D, Pang Y, Liu X, Wu J, Liang C, Zhou J.

Int Immunopharmacol. 2019 May;70:313-323. doi: 10.1016/j.intimp.2019.02.056. Epub 2019 Mar 7. Review.

PMID:
30852287
17.

K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.

Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku E.

Malar J. 2019 Mar 7;18(1):60. doi: 10.1186/s12936-019-2701-6.

18.

Targeting malaria parasite invasion of red blood cells as an antimalarial strategy.

Burns AL, Dans MG, Balbin JM, de Koning-Ward TF, Gilson PR, Beeson JG, Boyle MJ, Wilson DW.

FEMS Microbiol Rev. 2019 May 1;43(3):223-238. doi: 10.1093/femsre/fuz005. Review.

19.

Malaria: What's New in the Management of Malaria?

Plewes K, Leopold SJ, Kingston HWF, Dondorp AM.

Infect Dis Clin North Am. 2019 Mar;33(1):39-60. doi: 10.1016/j.idc.2018.10.002. Review.

20.

How can interventions that target forest-goers be tailored to accelerate malaria elimination in the Greater Mekong Subregion? A systematic review of the qualitative literature.

Nofal SD, Peto TJ, Adhikari B, Tripura R, Callery J, Bui TM, von Seidlein L, Pell C.

Malar J. 2019 Feb 1;18(1):32. doi: 10.1186/s12936-019-2666-5.

Supplemental Content

Loading ...
Support Center